PE (n = 12) | No PE (n = 38) | P-valuea | Others (n = 16) (Uncomplicated) | GH (n = 16) | P-valueb | Normotensive IUGR (n = 6) | P-valuec | Delivery < 34 weeks (n = 7) | Delivery ≥ 34 weeks (n = 44) | P-valued | |
---|---|---|---|---|---|---|---|---|---|---|---|
PlGF (pg/mL) | 105.6 (70.7-248.7) | 218.5 (131.2-322.5) | 0.041 | 274.6 (157.9-413.6) | 198.7 (91.5-305.3) | 0.142 | 165.9 (72.1-220.7) | 0.033 | 75.1 (64.6-131.7) | 221.7 (117.4-336.4) | 0.003 |
sFLT-1 (pg/mL) | 1879.0 (1379.5-2168.3) | 1144.0 (842.2-1882.8) | 0.046 | 1458.0 (1018.8-1896.3) | 1032.6 (826.8-1649.8) | 0.258 | 1324.4 (673.1-2012.0) | 0.768 | 2158.0 (1858.0-3463.0) | 1298.0 (846.1-1876.0) | 0.008 |
sFLT-1/PlGF ratio | 18.8 (4.8-29.1) | 6.2 (3.4-8.8) | 0.022 | 5.9 (2.9-8.6) | 5.9 (3.6-9.1) | 0.366 | 8.6 (4.0-19.6) | 0.161 | 29.4 (14.1-53.9) | 6.0 (3.4-9.0) | 0.001 |